CompanyStageLast valuationTotal raised
IImmunis, Inc.Immunis, Inc., founded in 2019 in Irvine, California, is a biotech company developing treatments for age- and disease-related immune decline.Series AHealthcareLast valuationUndisclosedTotal raisedSign inIInflammasome Therapeutics, Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$13.2MKKayak Therapeutics, Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$11.9MLLife Imapct Partners 9 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLife Impact Partners 10 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLife Impact Partners 11 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLife Impact Partners 12 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLife Impact Partners 13 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLife Impact Partners 14 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLife Impact Partners 15 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLife Impact Partners 1 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLife Impact Partners 2 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLife Impact Partners 3 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLife Impact Partners 4 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLife Impact Partners 5 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLife Impact Partners 6 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLife Impact Partners 7 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLife Impact Partners 8 LLCPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MLLifeward Ltd.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$11.2MMMyrtelle Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$16.7MNNEONC TECHNOLOGIES HOLDINGS, INC.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$5MNNeurofold Therapeutics Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$6.5MN
Nirrin Technologies, Inc.Won a federal SBIR/STTR research award from HHS and other federal agencies.Series AHealthcareLast valuationUndisclosedTotal raised$6.7MNNuclein, LLCNuclein, LLC, founded in 2017 in Austin, Texas, is developing a hand-held PCR test for infectious disease diagnosis.Series AHealthcareLast valuationUndisclosedTotal raisedSign inO
ONCOSYNERGY, INC.Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.Series AHealthcareLast valuationUndisclosedTotal raisedSign in